Amalgamated Bank’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-47,667
Closed -$995K 2998
2022
Q3
$995K Buy
47,667
+462
+1% +$9.62K 0.01% 1108
2022
Q2
$980K Buy
47,205
+844
+2% +$15K 0.01% 1164
2022
Q1
$778K Sell
46,361
-2,442
-5% -$42.7K 0.01% 1330
2021
Q4
$975K Sell
48,803
-840
-2% -$15.8K 0.01% 1243
2021
Q3
$901K Buy
49,643
+445
+0.9% +$10.2K 0.01% 1291
2021
Q2
$1.33M Buy
49,198
+38,874
+377% +$1.09M 0.01% 1147
2021
Q1
$309K Sell
10,324
-562
-5% -$19.2K 0.01% 1253
2020
Q4
$313K Buy
10,886
+1,626
+18% +$43.9K 0.01% 1206
2020
Q3
$226K Buy
+9,260
New +$200K 0.01% 1266
2020
Q2
Sell
-21,737
Closed -$177K 1696
2020
Q1
$177K Sell
21,737
-419
-2% -$4.79K ﹤0.01% 1401
2019
Q4
$292K Buy
22,156
+2,071
+10% +$25.1K 0.01% 1421
2019
Q3
$239K Sell
20,085
-269
-1% -$4.98K 0.01% 1453
2019
Q2
$498K Buy
20,354
+12,308
+153% +$355K 0.01% 1079
2019
Q1
$256K Buy
+8,046
New +$286K 0.01% 1359

Other funds holding CVET

Amalgamated Bank's CVET Position: Q4 2022 in Review

Amalgamated Bank sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 47,667 shares — an estimated $995K sold.

Amalgamated Bank first reported a position in CVET in Q1 2019 and held it in 14 quarters. The position peaked at $1.33M in Q2 2021. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

  • Amalgamated Bank reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Amalgamated Bank sold 47,667 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $995K.
  • Amalgamated Bank first reported a position in Covetrus, Inc. Common Stock in Q1 2019 and held it in 14 quarters.
  • Amalgamated Bank's Covetrus, Inc. Common Stock position peaked at $1.33M in Q2 2021.
  • 5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on Amalgamated Bank's 13F filing for Q4 2022, filed 10 Feb 2023.